Needleman S W
Department of Medicine, University of Maryland Cancer Center, Baltimore.
Am J Hematol. 1989 Oct;32(2):150-2. doi: 10.1002/ajh.2830320216.
Pure red cell aplasia (PRCA) is a rare disorder of erythrocyte production believed to have an autoimmune basis in most cases. Responses to a variety of immunosuppressive regimens are regularly observed, but toxicity is considerable. Brief responses to high-dose intravenous immunoglobulin (IVIg) have been previously reported. This case demonstrates a durable clinical remission of PRCA treated with IVIg and glucocorticoids.
纯红细胞再生障碍性贫血(PRCA)是一种罕见的红细胞生成障碍性疾病,多数情况下被认为具有自身免疫基础。对多种免疫抑制方案的反应经常可见,但毒性相当大。此前已有关于高剂量静脉注射免疫球蛋白(IVIg)的短暂反应的报道。本病例展示了用IVIg和糖皮质激素治疗PRCA后持久的临床缓解情况。